Bristol-Myers Squibb Company vs Vertex Pharmaceuticals Incorporated
Market cap comparison over time
Bristol-Myers Squibb Company
$128.4B
Rank #126
Vertex Pharmaceuticals Incorporated
$133.4B
Rank #123
Market Cap Over Time
Key Moments
- Vertex Pharmaceuticals Incorporated overtook Bristol-Myers Squibb Company by 2023
- Bristol-Myers Squibb Company overtook Vertex Pharmaceuticals Incorporated by 2024
- Vertex Pharmaceuticals Incorporated overtook Bristol-Myers Squibb Company by 2025
Year-by-Year Comparison
| Year | Bristol-Myers Squibb Company | Vertex Pharmaceuticals Incorporated | Leader |
|---|---|---|---|
| 2026 | $128.4B | $133.4B | Vertex Pharmaceuticals Incorporated |
| 2025 | $107.8B | $115.1B | Vertex Pharmaceuticals Incorporated |
| 2024 | $107.6B | $102.2B | Bristol-Myers Squibb Company |
| 2023 | $92.9B | $103.3B | Vertex Pharmaceuticals Incorporated |
| 2022 | $125.8B | $73.3B | Bristol-Myers Squibb Company |
| 2021 | $105.8B | $55.7B | Bristol-Myers Squibb Company |
| 2020 | $102.0B | $60.0B | Bristol-Myers Squibb Company |
| 2019 | $102.4B | $55.6B | Bristol-Myers Squibb Company |
| 2018 | $80.2B | $42.1B | Bristol-Myers Squibb Company |
| 2017 | $92.0B | $38.0B | Bristol-Myers Squibb Company |
| 2016 | $85.4B | $18.7B | Bristol-Myers Squibb Company |
| 2015 | $98.2B | $31.9B | Bristol-Myers Squibb Company |
| 2014 | $82.3B | $30.2B | Bristol-Myers Squibb Company |
| 2013 | $72.0B | $18.9B | Bristol-Myers Squibb Company |
| 2012 | $42.7B | $10.6B | Bristol-Myers Squibb Company |
| 2011 | $44.4B | $8.4B | Bristol-Myers Squibb Company |
| 2010 | $31.8B | $8.9B | Bristol-Myers Squibb Company |
| 2009 | $28.9B | $10.9B | Bristol-Myers Squibb Company |
| 2008 | $25.1B | $7.7B | Bristol-Myers Squibb Company |
| 2007 | $27.1B | $5.9B | Bristol-Myers Squibb Company |
| 2006 | $25.9B | $9.5B | Bristol-Myers Squibb Company |
| 2005 | $21.6B | $7.0B | Bristol-Myers Squibb Company |
| 2004 | $23.0B | $2.7B | Bristol-Myers Squibb Company |
| 2003 | $24.5B | $2.6B | Bristol-Myers Squibb Company |
| 2002 | $19.0B | $4.0B | Bristol-Myers Squibb Company |
| 2001 | $40.3B | $6.2B | Bristol-Myers Squibb Company |
| 2000 | $54.6B | $18.1B | Bristol-Myers Squibb Company |
| 1999 | $46.6B | $4.4B | Bristol-Myers Squibb Company |
| 1998 | $48.0B | $3.8B | Bristol-Myers Squibb Company |
| 1997 | $33.4B | $4.2B | Bristol-Myers Squibb Company |
| 1996 | $18.8B | $5.1B | Bristol-Myers Squibb Company |
| 1995 | $14.3B | $3.4B | Bristol-Myers Squibb Company |
| 1994 | $9.2B | $1.9B | Bristol-Myers Squibb Company |